Beryl Drugs Balance Sheet Annual

BSE: 524606 | NSE: - | ISIN: INE415H01017 | Sector: Biotechnology & Drugs

33.10 +0.57 (1.75%)Updated : 26 Nov 2024

Interim Data

Annual Data

Fiscal Period	2024	2023	2022	2021
Period End Date	Mar 24	Mar 23	Mar 22	Mar 21
Cash Equivalents	0.12	0.28	-	-
Short Term Investments	0.54	1.28	0.95	0.21
Cashand Short Term Investments	0.66	1.56	1.22	0.66
Accounts Receivable- Trade Net	7.58	6.90	4.45	4.54
Total Receivables Net	7.58	6.92	4.58	4.65
Total Inventory	1.26	1.05	2.98	2.27
Other Current Assets Total	0.72	0.79	1.85	2.58
Total Current Assets	10.22	10.32	10.63	10.15
Property/ Plant/ Equipment Total- Net	5.96	5.81	5.86	7.32
Intangibles Net	0.00	0.00	0.00	0.00
Long Term Investments	0.43	0.50	0.47	0.32
Other Long Term Assets Total	0.88	0.89	0.86	0.85
Total Assets	17.49	17.51	17.82	18.65
Accounts Payable	2.02	3.25	2.17	2.22
Current Portof LT Debt/ Capital Leases	2.69	0.23	0.25	0.78
Other Currentliabilities Total	1.05	1.26	2.70	2.86
Total Current Liabilities	5.76	6.33	8.49	8.21
Long Term Debt	2.40	2.72	1.68	1.99
Total Long Term Debt	2.40	2.72	1.68	1.99
Total Debt	5.09	4.54	5.29	5.12
Other Liabilities Total	0.40	0.40	0.36	0.31
Total Liabilities	8.56	9.45	10.53	10.72
Common Stock Total	5.09	5.09	5.09	5.09
Retained Earnings( Accumulated Deficit)	3.83	2.97	2.20	2.84
Total Equity	8.92	8.07	7.29	7.93
Total Liabilities Shareholders' Equity	17.49	17.51	17.82	18.65
Total Common Shares Outstanding	0.51	0.51	0.51	0.51
Tangible Book Valueper Share Common Eq	17.59	15.90	14.38	15.63
Notes Payable/ Short Term Debt	-	1.59	3.37	2.35
Other Equity Total	-	0.00	-	-
Cash	-	-	0.27	0.45
Deferred Income Tax	-	-	0.00	0.21